美国 · SEC FORM 4
Aclaris Therapeutics, Inc.
ACRS · Nasdaq · CIK 0001557746 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
11 同一窗口内观察到的 Form 4 交易行
1 sales · 10 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-11-19 · Mehra Anand.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -29.0%
- 3M
- -20.0%
- 6M
- +4.5%
- 12M
- —
波动率与流动性
- 波动率
- 99.1%
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- -829.6%
- ROE
- -63.0%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-04 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 18,191,280
- 上期报告
- 16,075,295
- 日均成交量
- 2,808,944
- 回补天数
- 6.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-11-19 | Mehra Anand | 买入 (P) | Common Stock | 666,666 | USD 2.25 | USD 1,499,998 | SEC 申报 ↗ |
| 2024-08-05 | Leonard Braden Michael | 买入 (P) | Common Stock | 206,025 | USD 1.24 | USD 255,471 | SEC 申报 ↗ |
| 2024-08-02 | Leonard Braden Michael | 买入 (P) | Common Stock | 167,544 | USD 1.29 | USD 216,132 | SEC 申报 ↗ |
| 2024-07-31 | Leonard Braden Michael | 买入 (P) | Common Stock | 100,000 | USD 1.33 | USD 133,000 | SEC 申报 ↗ |
| 2024-07-30 | Leonard Braden Michael | 买入 (P) | Common Stock | 173,730 | USD 1.30 | USD 225,849 | SEC 申报 ↗ |
| 2024-07-22 | Leonard Braden Michael | 买入 (P) | Common Stock | 17,716 | USD 1.33 | USD 23,562 | SEC 申报 ↗ |
| 2024-07-19 | Leonard Braden Michael | 买入 (P) | Common Stock | 6,689 | USD 1.30 | USD 8,696 | SEC 申报 ↗ |
| 2024-07-18 | Leonard Braden Michael | 买入 (P) | Common Stock | 130,317 | USD 1.30 | USD 169,412 | SEC 申报 ↗ |
| 2024-07-05 | Leonard Braden Michael | 买入 (P) | Common Stock | 123,017 | USD 1.15 | USD 141,470 | SEC 申报 ↗ |
| 2024-07-03 | Leonard Braden Michael | 买入 (P) | Common Stock | 143,288 | USD 1.16 | USD 166,214 | SEC 申报 ↗ |
| 2024-07-02 | Leonard Braden Michael | 买入 (P) | Common Stock | 86,092 | USD 1.14 | USD 98,145 | SEC 申报 ↗ |
| 2024-07-01 | Leonard Braden Michael | 买入 (P) | Common Stock | 107,434 | USD 1.14 | USD 122,475 | SEC 申报 ↗ |
| 2024-06-28 | Leonard Braden Michael | 买入 (P) | Common Stock | 1,201,000 | USD 1.12 | USD 1,349,120 | SEC 申报 ↗ |
| 2024-06-27 | Leonard Braden Michael | 买入 (P) | Common Stock | 235,000 | USD 1.15 | USD 270,250 | SEC 申报 ↗ |
| 2024-06-18 | Leonard Braden Michael | 买入 (P) | Common Stock | 50,000 | USD 1.13 | USD 56,500 | SEC 申报 ↗ |
Form 4 申报证据
39 transaction lines in the latest 365-day window; 393 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-01 | Kolbeck Roland Wilhelm | 期权行权／转换 (M) | Common Stock | 36,375 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-01 | Kolbeck Roland Wilhelm | 代扣税 (F) | Common Stock | 12,385 | USD 5.20 | USD 64,402 | SEC 申报 ↗ |
| 2026-06-05 | SCHIFF ANDREW N | 期权行权／转换 (M) | Common Stock | 11,580 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-01 | Kolbeck Roland Wilhelm | 期权行权／转换 (M) | Common Stock | 36,375 | USD — | USD — | SEC 申报 ↗ |
| 2026-08-01 | Kolbeck Roland Wilhelm | 代扣税 (F) | Common Stock | 12,385 | USD 5.20 | USD 64,402 | SEC 申报 ↗ |
| 2026-06-05 | SCHIFF ANDREW N | 期权行权／转换 (M) | Common Stock | 11,580 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-05 | Molineaux Christopher P. | 期权行权／转换 (M) | Common Stock | 11,580 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-05 | Mehra Anand | 期权行权／转换 (M) | Common Stock | 11,580 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-05 | MILANO VINCENT | 期权行权／转换 (M) | Common Stock | 11,580 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-05 | Humphries William D. | 期权行权／转换 (M) | Common Stock | 11,580 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-05 | GOWEN MAXINE | 期权行权／转换 (M) | Common Stock | 11,580 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-01 | Hall Jesse Wayne | 期权行权／转换 (M) | Common Stock | 36,375 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-01 | Hall Jesse Wayne | 代扣税 (F) | Common Stock | 9,330 | USD 4.41 | USD 41,145 | SEC 申报 ↗ |
| 2026-04-23 | Leonard Braden Michael | 卖出 (S) | Common Stock | 300,000 | USD 4.53 | USD 1,359,000 | SEC 申报 ↗ |
| 2026-03-01 | Balthaser Kevin | 期权行权／转换 (M) | Common Stock | 2,375 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-01 | Balthaser Kevin | 代扣税 (F) | Common Stock | 677 | USD 2.87 | USD 1,943 | SEC 申报 ↗ |
| 2026-02-03 | Walker Neal | 期权行权／转换 (M) | Common Stock | 63,475 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-03 | Walker Neal | 代扣税 (F) | Common Stock | 18,611 | USD 3.47 | USD 64,580 | SEC 申报 ↗ |
| 2026-02-03 | Loerop James | 期权行权／转换 (M) | Common Stock | 20,875 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-03 | Loerop James | 代扣税 (F) | Common Stock | 5,937 | USD 3.47 | USD 20,601 | SEC 申报 ↗ |
| 2026-02-03 | Davis Hugh M. | 期权行权／转换 (M) | Common Stock | 18,675 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-03 | Balthaser Kevin | 期权行权／转换 (M) | Common Stock | 22,025 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-03 | Balthaser Kevin | 代扣税 (F) | Common Stock | 6,449 | USD 3.47 | USD 22,378 | SEC 申报 ↗ |
| 2026-02-01 | Loerop James | 期权行权／转换 (M) | Common Stock | 33,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-01 | Loerop James | 代扣税 (F) | Common Stock | 10,686 | USD 3.51 | USD 37,508 | SEC 申报 ↗ |
| 2026-02-01 | Balthaser Kevin | 期权行权／转换 (M) | Common Stock | 14,750 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-01 | Balthaser Kevin | 代扣税 (F) | Common Stock | 4,984 | USD 3.51 | USD 17,494 | SEC 申报 ↗ |
| 2026-01-02 | Walker Neal | 期权行权／转换 (M) | Common Stock | 29,150 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-02 | Walker Neal | 代扣税 (F) | Common Stock | 9,952 | USD 2.88 | USD 28,662 | SEC 申报 ↗ |
| 2026-01-02 | Loerop James | 期权行权／转换 (M) | Common Stock | 18,150 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-02 | Loerop James | 代扣税 (F) | Common Stock | 6,171 | USD 2.88 | USD 17,772 | SEC 申报 ↗ |
| 2026-01-02 | Balthaser Kevin | 期权行权／转换 (M) | Common Stock | 13,200 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-02 | Balthaser Kevin | 代扣税 (F) | Common Stock | 4,461 | USD 2.88 | USD 12,848 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ACRS |
| CIK | 0001557746 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 393 transaction lines from 2020-02-03 to 2026-08-01 28 P purchase lines · 78 S sale lines · 287 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.